| R11526 |
YC6 |
N/A
|
| R11527 |
Lusutrombopag (Synonyms: S-888711) |
Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, u
|
| R11529 |
DBeQ (JRF 12) |
DBeQ is a selective, potent, reversible, and ATP-competitive p97 inhibitor with
|
| R11530 |
RG2833 (RGFP109) |
RG2833 (RGFP109) is a brain-penetrant HDAC inhibitor with IC50 of 60 nM and 50 n
|
| R11531 |
GSK0660 |
GSK0660 is a specific antagonist of PPARβ/δ, also has inverse agonist effects wh
|
| R11532 |
VU0357017 hydrochloride (CID-25010775) |
VU0357017 hydrochloride is a highly selective M1 agonists that appear to act at
|
| R11533 |
KS176 |
KS176 is a potent and selective inhibitor of the breast cancer resistance protei
|
| R11534 |
VU0361737 |
VU 0361737 is a selective positive allosteric modulator (PAM) for mGlu4 receptor
|
| R11535 |
NSC59984 |
NSC59984 is a p53 pathway activator via induction of mutant p53 protein degradat
|
| R11536 |
PD168393 |
PD168393 is an irreversible EGFR inhibitor with IC50 of 0.70 nM, irreversibly al
|
| R11537 |
Selisistat (EX-527) |
EX 527 (Selisistat) is a potent and selective SIRT1 inhibitor with IC50 of 38 nM
|
| R11538 |
NOD-IN-1 |
NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domai
|
| R11539 |
ML348 |
ML348 is a selective and reversible lysophospholipase 1 (LYPLA1) inhibitor (IC50
|
| R11540 |
JK184 |
JK184 is a potent Hedgehog (Hh) pathway inhibitor with IC50 of 30 nM in mammalia
|
| R11541 |
VU0357121 |
VU0357121 is a novel positive allosteric modulator (PAM) of mGlu5 with EC50 of 3
|
| R11542 |
VU0364770 |
VU 0364770 is a positive allosteric modulator(PAM) of mGlu4 with
|
| R11543 |
NSC23005 Sodium |
NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM)
|
| R11544 |
NSC23005 |
NSC23005 is a novel and effective p18 inhibitor (ED50=5.21 nM) in prom
|
| R11545 |
URB602 |
URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits ra
|
| R11546 |
MQAE |
MQAE is a fluorescent chloride ion indicator that is more sensitive and selectiv
|
| R11547 |
STATTIC |
Stattic, the first nonpeptidic small molecule, potently inhibits STAT3 activatio
|
| R11549 |
LEE011;Ribociclib;CDK4-IN-1 |
CDK4-IN-1 is a selective inhibitor of cyclin-dependent kinase 4.N/A
|
| R11550 |
Dovitinib |
Dovitinib (TKI258) Lactate is the Lactate of Dovitinib, which is a multitargeted
|
| R11551 |
Dolutegravir sodium (Synonyms: S/GSK1349572 sodium) |
Dolutegravir (GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC
|
| R11552 |
BFH-772 |
BFH772 is a novel potent oral VEGFR2 inhibitor, targeting VEGFR2 kinase with IC5
|